근시 및 노안 치료 시장 규모, 점유율, 동향 분석 보고서 : 근시별, 노안별, 지역별 및 부문별 예측(2026-2033년)

Myopia And Presbyopia Treatment Market Summary

The global myopia and presbyopia treatment market size was valued at USD 21.8 billion in 2025 and is estimated to reach USD 45.4 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. The myopia and presbyopia treatment market is experiencing steady growth, driven by the rising global burden of vision disorders, increasing screen time, aging populations, and growing awareness of eye health.

Lifestyle changes such as prolonged digital device usage and reduced outdoor activity are significantly contributing to the increase in refractive errors, especially among children and working adults. According to the World Health Organization, at least 2.2 billion people globally have a vision impairment or blindness, with a large proportion being preventable or treatable. These factors, combined with improved access to eye care services and technological advancements, are accelerating demand for effective treatment solutions.

Myopia (nearsightedness) is a condition where distant objects appear blurred due to elongation of the eyeball or improper focusing of light on the retina. It is increasingly common among children and young adults. Presbyopia, on the other hand, is an age-related condition that typically affects individuals over 40 and is caused by the gradual loss of the eye's ability to focus on nearby objects. Both conditions require vision correction through glasses, contact lenses, surgery, or emerging pharmacological treatments. The increasing prevalence of these conditions is creating sustained demand for a wide range of treatment options.

One of the key drivers of market growth is the rapid increase in myopia prevalence worldwide. A recent global analysis published in the British Journal of Ophthalmology and reported by The Guardian in September 2024 highlights that myopia cases are increasing rapidly worldwide, with projections suggesting that over 740 million children and teenagers could be affected by 2050, and global prevalence may reach nearly 40% among young populations. This surge is particularly evident in Asia Pacific countries, where urbanization, education patterns, and digital lifestyles are contributing to the early onset and progression of myopia. As a result, there is a growing demand for myopia management solutions such as specialty lenses, orthokeratology, and low-dose atropine therapy.

Global Myopia And Presbyopia Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global myopia and presbyopia treatment market report based on myopia treatment type, presbyopia treatment type, and region:

• Myopia Treatment Type Outlook (Revenue, USD Unit, 2021 - 2033)
• Corrective
  • Prescription lenses
  • Single
  • Bifocal
  • Trifocal
  • Others
  • Contact lenses
• Surgical
• Drugs
• Presbyopia Treatment Type Outlook (Revenue, USD Unit, 2021 - 2033)
• Prescription Lenses
  • Reading Glasses
  • Bifocals
  • Trifocals
  • Progressive Multifocals
  • Office Progressives
• Contact Lenses
  • Bifocal
  • Multifocal
  • Monovision
  • Modified Monovision
• Intraocular Lenses
• Refractive Surgery
• Region Outlook (Revenue, USD Unit, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Thailand
  • Australia
  • India
• Latin America
  • Brazil
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Myopia Treatment Type
  • 1.2.2. presbyopia Treatment Type
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Myopia treatment type outlook
  • 2.2.2. presbyopia treatment type outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Myopia And Presbyopia Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Myopia And Presbyopia Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Myopia And Presbyopia Treatment Market: Myopia Treatment Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Myopia And Presbyopia Treatment Market: Myopia Treatment Type Movement Analysis
• 4.3. Myopia And Presbyopia Treatment Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Corrective
  • 4.5.1. Corrective Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Prescription Lenses
    • 4.5.2.1. Prescription Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.1. Single
        • 4.5.2.1.1.1. Single Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.2. Bifocal
        • 4.5.2.1.2.1. Bifocal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.3. Trifocal
        • 4.5.2.1.3.1. Trifocal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.4. Others
        • 4.5.2.1.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Contact Lenses
    • 4.5.3.1. Contact Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Surgical
  • 4.6.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Drugs
  • 4.7.1. Drugs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Myopia And Presbyopia Treatment Market: Presbyopia Treatment Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Myopia And Presbyopia Treatment Market: Presbyopia Treatment Type Movement Analysis
• 5.3. Myopia And Presbyopia Treatment Market by Presbyopia Treatment Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Prescription Lenses
  • 5.5.1. Prescription Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Reading Glasses
    • 5.5.2.1. Reading Glasses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Bifocals
    • 5.5.3.1. Bifocals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Trifocals
    • 5.5.4.1. Trifocals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Progressive Multifocals
    • 5.5.5.1. Progressive Multifocals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.6. Office Progressives
    • 5.5.6.1. Office Progressives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Contact Lenses
  • 5.6.1. Contact Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Bifocal
    • 5.6.2.1. Bifocal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Multifocal
    • 5.6.3.1. Multifocal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. Monovision
    • 5.6.4.1. Monovison Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.5. Modified Monovision
    • 5.6.5.1. Modifies Monovision Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Intraocular Lenses
  • 5.7.1. Intraocular Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Refractive Surgery
  • 5.8.1. Refractive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Myopia And Presbyopia Treatment Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Myopia And Presbyopia Treatment Market Movement Analysis
• 6.3. Myopia And Presbyopia Treatment Market: Regional Estimates & Trend Analysis by Myopia Treatment Type & Presbyopia Treatment Type
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. North America
  • 6.5.1. North America Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. UK Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. Germany Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.9. France
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. France Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Italy Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Spain Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Denmark Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Sweden Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1. Key Country Dynamics
    • 6.5.14.2. Competitive Scenario
    • 6.5.14.3. Regulatory Framework
    • 6.5.14.4. Reimbursement scenario
    • 6.5.14.5. Norway Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Japan Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. China Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. India Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. South Korea Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Australia Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Thailand Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Brazil Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Argentina Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. Colombia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Colombia Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. South Africa Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Saudi Arabia Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. UAE Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Kuwait Myopia And Presbyopia Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Ziemer Ophthalmic Systems AG
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Product Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. NIDEK CO., LTD.
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Product Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. Johnson & Johnson Vision
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Product Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Essilor Ltd.
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Product Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. Zeiss International
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Product Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. ALCON VISION LLC
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Product Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. Bausch & Lomb Incorporated
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Product Benchmarking
    • 7.2.7.4. Strategic Initiatives
  • 7.2.8. Haag-Streit UK
    • 7.2.8.1. Company Overview
    • 7.2.8.2. Financial Performance
    • 7.2.8.3. Product Benchmarking
    • 7.2.8.4. Strategic Initiatives
  • 7.2.9. Topcon Corporation
    • 7.2.9.1. Company Overview
    • 7.2.9.2. Financial Performance
    • 7.2.9.3. Product Benchmarking
    • 7.2.9.4. Strategic Initiatives